DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR POLIDOCANOL

« Back to Dashboard

Clinical Trials for Polidocanol

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00161915	Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices	Completed	Baxter Healthcare Corporation	Phase 3	The purpose of this study was to assess whether endoscopic sclerotherapy with Fibrin Sealant was superior to ligature, with or without Polidocanol, in achieving hemostasis in bleeding esophageal varices and preventing rebleeding. Therapeutic success was defined as survival of the first seven days without clinically significant bleeding.
NCT00377910	The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy	Completed	Aarhus University Hospital	Phase 4	Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.
NCT00377910	The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy	Completed	Northern Orthopaedic Division, Denmark	Phase 4	Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.
NCT00399451	Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)	Unknown status	Liaoyang Central Hospital	Phase 1/Phase 2	The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.

Clinical Trial Conditions for Polidocanol

Condition Name

Condition Name for Polidocanol
Intervention	Trials
Varicose Veins	9
Veins, Varicose	1
Epicondylitis	1
Snoring	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Polidocanol
Intervention	Trials
Varicose Veins	11
Tendinopathy	2
Cysts	1
Gastroesophageal Reflux	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Polidocanol

Trials by Country

Trials by Country for Polidocanol
Location	Trials
United States	38
Germany	2
Brazil	2
United Kingdom	2
Denmark	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Polidocanol
Location	Trials
Washington	6
North Carolina	4
California	3
Florida	3
New York	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Polidocanol

Clinical Trial Phase

Clinical Trial Phase for Polidocanol
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	4
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Polidocanol
Clinical Trial Phase	Trials
Completed	10
Not yet recruiting	3
Unknown status	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Polidocanol

Sponsor Name

Sponsor Name for Polidocanol
Sponsor	Trials
BTG International Inc.	8
UPECLIN HC FM Botucatu Unesp	2
Fundação de Amparo à Pesquisa do Estado de São Paulo	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Polidocanol
Sponsor	Trials
Other	21
Industry	1

Export unavailable in trial.
Subscribe for complete access.